Monte Rosa Therapeutics, Inc. (GLUE)
13.78
-0.52
(-3.67%)
USD |
NASDAQ |
Aug 24, 16:00
13.77
0.00 (0.00%)
After-Hours: 20:00
Monte Rosa Therapeutics Price to Book Value : 2.409 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 2.409 |
| August 21, 2026 | 2.501 |
| August 20, 2026 | 2.585 |
| August 19, 2026 | 2.758 |
| August 18, 2026 | 2.629 |
| August 17, 2026 | 2.69 |
| August 14, 2026 | 2.711 |
| August 13, 2026 | 2.770 |
| August 12, 2026 | 2.790 |
| August 11, 2026 | 2.756 |
| August 10, 2026 | 2.767 |
| August 07, 2026 | 2.777 |
| August 06, 2026 | 2.748 |
| August 05, 2026 | 2.730 |
| August 04, 2026 | 2.812 |
| August 03, 2026 | 2.69 |
| July 31, 2026 | 2.889 |
| July 30, 2026 | 3.967 |
| July 29, 2026 | 3.771 |
| July 28, 2026 | 3.855 |
| July 27, 2026 | 3.946 |
| July 24, 2026 | 3.984 |
| July 23, 2026 | 4.028 |
| July 22, 2026 | 4.161 |
| July 21, 2026 | 4.133 |
| Date | Value |
|---|---|
| July 20, 2026 | 4.107 |
| July 17, 2026 | 4.296 |
| July 16, 2026 | 4.051 |
| July 15, 2026 | 4.094 |
| July 14, 2026 | 4.103 |
| July 13, 2026 | 3.844 |
| July 10, 2026 | 4.030 |
| July 09, 2026 | 4.289 |
| July 08, 2026 | 4.208 |
| July 07, 2026 | 4.268 |
| July 06, 2026 | 4.066 |
| July 02, 2026 | 4.234 |
| July 01, 2026 | 4.201 |
| June 30, 2026 | 4.233 |
| June 29, 2026 | 3.861 |
| June 26, 2026 | 3.601 |
| June 25, 2026 | 3.499 |
| June 24, 2026 | 3.369 |
| June 23, 2026 | 3.346 |
| June 22, 2026 | 3.016 |
| June 18, 2026 | 2.958 |
| June 17, 2026 | 2.974 |
| June 16, 2026 | 2.869 |
| June 15, 2026 | 2.928 |
| June 12, 2026 | 2.946 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Nurix Therapeutics, Inc. | 6.766 |
| Gilead Sciences, Inc. | 15.39 |
| Ironwood Pharmaceuticals, Inc. | -- |
| Capricor Therapeutics, Inc. | 1.605 |
| Cue Biopharma, Inc. | 52.48 |
Price to Book Value Related Metrics
| PS Ratio | 41.87 |
| Price | 13.78 |
| Earnings Yield | -13.84% |
| Market Cap | 1.174B |